Post‐chemotherapy alopecia: what the dermatologist needs to know

It is estimated that chemotherapy‐induced alopecia (CIA) occurs in 65% of chemotherapeutic patients. Forty‐seven percent of cancer patients consider hair loss to be the most traumatic aspect of therapy. CIA can be anticipated, depending on the regimen used, and doctors should be aware of the treatme...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of dermatology Vol. 60; no. 11; pp. 1313 - 1317
Main Authors Santos, Thuany Silva, Hernandéz Galvis, Kely, Vañó Galván, Sergio, Saceda‐Corralo, David
Format Journal Article
LanguageEnglish
Published Hoboken Blackwell Publishing Ltd 01.11.2021
Subjects
Alopecia
Baldness
Chemotherapy
Patients
Online AccessGet full text

Cover

More Information
Summary:It is estimated that chemotherapy‐induced alopecia (CIA) occurs in 65% of chemotherapeutic patients. Forty‐seven percent of cancer patients consider hair loss to be the most traumatic aspect of therapy. CIA can be anticipated, depending on the regimen used, and doctors should be aware of the treatments that can minimize it. Careful evaluation before chemotherapy treatment should be performed, and trichoscopy may be useful. Dermatologists do not generally evaluate postchemotherapy alopecia. However, there is an increasing number of reports of permanent chemotherapy‐induced alopecia, and these patients require treatment.
Bibliography:Conflict of interest: None.
Funding source: None.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0011-9059
1365-4632
DOI:10.1111/ijd.15812